About APC
Information for the Media
Press inquiries
Please direct all inquiries to CEO Scott Brunner, CAE
Email: info@a4pc.org
Phone: (281) 933-8400
News Releases (2020-2021)
26 October 2020
FDA POSTS FINAL MOU: Disappointing … but not surprising
16 October 2020
Tricare steps back from compounding recoupment (APC/NCPA joint release)
2 July 2020
APC releases statement on NASEM’s cBHT review
14 May 2020
APC statement on the FDA’s draft Memorandum of Understanding on interstate distribution
13 May 2020
What APC stands for
The Alliance for Pharmacy Compounding is the voice for pharmacy compounding, representing compounding pharmacists and technicians in both 503A and 503B settings, as well as prescribers, educators, researchers, and suppliers.
In traditional compounding, pharmacists create a customized medication, most often from raw ingredients, for an individual patient pursuant to a prescription. Pharmacists’ ability to compound medications from pure ingredients is authorized in federal law and for good reason: Manufactured drugs don’t come in strengths and dosage forms that are right for everyone, and physicians need to be able to prescribe customized medications when, in their judgment, a manufactured drug is not the best course of therapy for a human or animal patient.
Every day, APC members play a critical role in patients’ lives, preparing essential, custom medications for a range of health conditions, including autism, oncology, dermatology, ophthalmology, pediatrics, women’s health, animal health, and others.
